A Stability Indicating Reverse Phase-HPLC Method Development and Validation for the Estimation of Bimatoprost 0.3% & Timolol 0.5% Pharmaceutical Ophthalmic Dosage Form

ISSN Print: 2156-8251
ISSN Online: 2156-8278
www.scirp.net/journal/ajac
E-mail: [email protected]

Citations

"A Stability Indicating Reverse Phase-HPLC Method Development and Validation for the Estimation of Bimatoprost 0.3% & Timolol 0.5% Pharmaceutical Ophthalmic Dosage Form"
written by Md. S. Amin, Muhammad T. Islam,
published by American Journal of Analytical Chemistry, Vol.13 No.12, 2022

has been cited by the following article(s):

No relevant information.

[1]	Comprehensive review of analytical techniques for evaluating fixed-dose combinations containing timolol Results in Chemistry, 2025 DOI:10.1016/j.rechem.2025.102309

[2]	Simultaneous quantification of some prostaglandin analogs used in the treatment of open-angle glaucoma by RP-HPLC Microchemical Journal, 2025 DOI:10.1016/j.microc.2025.113775